Center for U S Policy Files FDA Citizen Petition to Protect Marginalized Patients
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.
Center for U S Policy Files FDA Citizen Petition to Protect Marginalized Patients
theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
Center for U S Policy Files FDA Citizen Petition to Protect Marginalized Patients
phoenixherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from phoenixherald.com Daily Mail and Mail on Sunday newspapers.
Salix Pharmacetuicals Will Present Scientific Data Featuring Post Hoc Analyses For RELISTOR® (Methylnaltrexone Bromide) At ASRA s 46th Annual Spring Meeting
News provided by
Share this article
Share this article
BRIDGEWATER, N.J., May 13, 2021 /PRNewswire/ Salix Pharmaceuticals ( Salix ), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases, today announced that two RELISTOR® (methylnaltrexone bromide) scientific posters will be presented at the 46th Annual Regional Anesthesiology and Acute Pain Medicine Meeting being held May 13 – 15, 2021. The meeting is hosted by The American Society of Regional Anesthesia and Pain Medicine (ASRA).
The following posters will be presented on Thursday, May 13 from 10:30 a.m. – 12:00 p.m. ET: